Pfizer, AstraZeneca and Moderna have won acceptance for their Covid vaccines from the Uk regulator and the jabs are currently getting rolled out. But what about the other vaccine candidates and how soon will they occur to market place?
Our record gives a snapshot of what the vaccine landscape appears to be like.
The life sciences industry’s reaction to the pandemic has been unprecedented equally in terms of the velocity at which it has made vaccines and its willingness to collaborate with rivals. That has resulted in 237 potential vaccines, of which 64 are in human medical trials.
Which is good information as, in the vaccines business there is generally no “just one-dimensions-suits-all” solution, with various international locations demanding various sorts of vaccines primarily based on a array of variables which include weather, land mass and demography. In other terms: there is loads of place in the market place for far more than just one vaccine.
Covid vaccines approved by the Uk
Pfizer/BioNtech
Uk acceptance date: December 2, 2020
Doses: 2
Efficacy: 90pc +
Style: mRNA
Doses sold or pre-ordered globally: The complete sum is undisclosed, but we know it has 300m on get from the EU and 200m from the US, which, alongside one another with the Uk, brings the complete to 540m
Doses procured by the Uk: 40m
Manufacturing capability: Up to 2bn doses this 12 months